Prestige Consumer Healthcare
PBH
#3933
Rank
NZ$5.21 B
Marketcap
NZ$105.87
Share price
0.95%
Change (1 day)
-26.58%
Change (1 year)

Earnings for Prestige Consumer Healthcare (PBH)

Earnings in 2025 (TTM): NZ$0.49 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are NZ$1.11 Billion. In 2024 the company made an earning of NZ$0.47 Billion, an increase over its 2023 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prestige Consumer Healthcare from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.49 B3.13%
2024 NZ$0.47 B-405.61%
2023 -NZ$0.16 Billion-134.07%
2022 NZ$0.45 B10.21%
2021 NZ$0.41 B12.88%
2020 NZ$0.36 B-657.8%
2019 -NZ$66.2 Million-143.45%
2018 NZ$0.15 B-50.46%
2017 NZ$0.30 B52.98%
2016 NZ$0.20 B-31.39%
2015 NZ$0.29 B45.68%
2014 NZ$0.20 B10.59%
2013 NZ$0.18 B38.24%
2012 NZ$0.13 B8.79%
2011 NZ$0.12 B55.18%
2010 NZ$77.91 M-123.77%
2009 -NZ$0.33 Billion-446.47%
2008 NZ$94.61 M8.03%
2007 NZ$87.58 M-3.71%
2006 NZ$90.95 M42.33%
2005 NZ$63.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
NZ$16.06 B 3,170.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$20.42 B 4,058.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-NZ$2.4 Billion-588.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.82 B 11,266.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$75.34 M-84.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$28.29 B 5,660.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$37.78 B 7,593.06%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$10.33 B 2,004.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$1.73 B 253.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.02 B 2,755.21%๐Ÿ‡บ๐Ÿ‡ธ USA